Toronto, ON (PRWEB) April 10, 2023 Diversity in mRNA therapies has mitigated advancements in the processes for mRNA manufacturing. In vitro transcribed
The varying impurity profiles of mRNA from the IVT step calls on options in purification technologies that would allow process development scientists to mix and match media based on the specific characteristics of the molecule.